S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
S&P 500   3,841.94
DOW   31,496.30
QQQ   308.68
pixel
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Stoke TherapeuticsLigand PharmaceuticalsADC TherapeuticsSeres TherapeuticsPraxis Precision Medicines
SymbolNASDAQ:STOKNASDAQ:LGNDNYSE:ADCTNASDAQ:MCRBNASDAQ:PRAX
Price Information
Current Price$54.01$144.40$22.75$19.06$36.42
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.21.61.61.71.8
Analysis Score2.43.33.43.43.5
Community Score2.92.93.32.95.0
Dividend Score0.00.00.00.00.0
Ownership Score0.80.00.81.70.0
Earnings & Valuation Score0.01.90.60.60.6
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$62.17$215.60$47.50$38.17$60.33
% Upside from Price Target15.10% upside49.31% upside108.79% upside100.24% upside65.66% upside
Trade Information
Market Cap$1.81 billion$2.40 billion$1.57 billion$1.74 billion$1.39 billion
Beta0.631.46N/A4.07N/A
Average Volume137,870775,696233,1451,066,282118,557
Sales & Book Value
Annual RevenueN/A$120.28 million$2.34 million$34.51 millionN/A
Price / SalesN/A19.94669.7850.40N/A
CashflowN/A$7.77 per shareN/AN/AN/A
Price / CashN/A18.58N/AN/AN/A
Book Value$6.86 per share$43.68 per shareN/A($0.69) per shareN/A
Price / BookN/A3.31-27.62N/A
Profitability
Net Income$-32,330,000.00$629.30 million$-116,480,000.00$-70,280,000.00N/A
EPS($1.80)$2.11($2.36)($1.20)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/A28.48N/AN/AN/A
P/E GrowthN/A1.46N/AN/AN/A
Net MarginsN/A-11.23%N/A-385.22%N/A
Return on Equity (ROE)-22.93%5.90%N/A-2,867.98%N/A
Return on Assets (ROA)-22.26%3.22%N/A-51.24%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.65%0.28%0.13%N/A
Current Ratio29.02%20.28%15.55%6.73%N/A
Quick Ratio29.02%19.96%15.55%6.73%N/A
Ownership Information
Institutional Ownership PercentageN/AN/A40.88%94.32%N/A
Insider Ownership Percentage54.60%10.60%N/A4.80%N/A
Miscellaneous
Employees56115N/A10850
Shares Outstanding33.47 million16.61 million68.89 million91.25 million38.26 million
Next Earnings Date3/22/2021 (Estimated)5/5/2021 (Estimated)3/11/2021 (Estimated)5/6/2021 (Estimated)N/A
OptionableNot OptionableOptionableNot OptionableOptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.